Introduction
Seroma is the abnormal accumulation of serous fluid in a dead space containing plasma and lymphatic fluid.[1][2][3] It is a common complication of breast cancer surgery, plastic surgery, and abdominal wall hernia repair, with rates ranging between 15 to 85% following mastectomy and a global prevalence of 10.9% following abdominoplasty.[4][5][6]
The etiology of seroma formation remains unclear but is thought to be due to disruption of lymphatic and vascular drainage through extensive soft tissue dissection with an accumulation of serum, and possibly inflammatory exudate, in a dead space.[7][8]
These fluid collections can cause pain and anxiety for the patient necessitating further outpatient and hospital visits, leading to increased cost of care. Local wound complications can occur, such as wound dehiscence and flap necrosis, requiring further surgical intervention.[9] They are also associated with an increased risk of wound infection and possible abscess formation.[10]
Although current research trends are focussed on prevention, the mainstay of postoperative management of seroma includes conservative measures and fine needle aspirations.[11]
Anatomy and Physiology
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
Surgical wounds will heal through primary intention in the presence of well-approximated tissues and the absence of infection. This occurs over three overlapping phases: hemostasis/inflammation, proliferation, and maturation. Disruption of this process through infection, hypoxia, or dehiscence will lead to secondary wound healing. This occurs through the formation of granulation tissue (consisting of fibroblasts, new blood vessels, and type III collagen) with overlying epithelialization and extensive remodeling. Decelerated angiogenesis and epithelialization make this a slower mode of healing and more likely to result in chronic wounds or infection without good wound care.[12][13] It is thought this delayed form of healing plays a role in the formation of seroma due to a prolonged phase of the first phase of wound repair.
The exact pathophysiology of seroma formation is not yet fully understood. Current hypotheses from different studies indicate a likely multifactorial origin of this fluid collection. Surgical procedures with extensive soft tissue dissection are more likely to transect blood and lymphatic vessels and lead to a transudative fluid collection. Cases that have undergone significant resection of tissue result in a large potential dead space, making it more difficult for flaps to adhere and creating shearing forces between tissue surfaces. This is thought to contribute to an inflammatory process with exudative fluid from tissues adding to seroma formation.[7][11]
Multiple studies have analyzed fluid aspirated from seromas to investigate its chemical and cellular components, with conflicting findings suggestive of both a lymph-like fluid and fluid similar to inflammatory exudate.[8][14][15]
Chronic, unsuccessfully treated seromas may rarely lead to pseudocyst formation, lined by a dense capsule consisting of fibrous tissue and hyaline degenerated collagen. The incidence and pathophysiology of this encapsulated seroma remain poorly understood, with current evidence limited to case reports.[16][17][18][19]
Indications
Seromas that are minimal in volume and do not cause any pain, functional deficit, or strain on the wound closure can be managed conservatively with observation. In most cases, these will reabsorb without the need for further intervention.
Large volume seromas greater than 75 to 100 ml are often associated with pain, infection, and reduced function of the associated area, such as shoulder movement in axillary seromas.[20] Aspiration may be carried out in these cases to treat the patient’s symptoms. In instances where recollection occurs, multiple aspirations may be required. Ultrasound-guided aspiration is indicated in patients with periprosthetic seroma, such as in patients with breast implants, due to the risk of rupture.[21]
Open surgical drainage and debridement are rarely required and reserved for chronic cases with encapsulated pseudocyst formation or in cases where there is superimposed infection.[20]
Contraindications
Contraindications to seroma aspiration include:
- Small volume seromas that are not causing pain, functional deficit, or compromise to wound closure
- Presence of a pulsatile mass
Equipment
- Clean trolley
- Dressing pack
- Skin disinfectant wipe/device
- 18G needle or cannula
- Sterile syringe 20, 30, or 50 ml
- Universal container for specimen collection
- Disposable gloves and apron
- Sterile gauze
- Sharps container
- Disposable absorbent pad
- Disposable waste bag
- Sterile dressing
For potentially complex or periprosthetic seromas, consider radiologically guided aspiration.
Personnel
Seroma aspiration can routinely be carried out by an individual clinician at the patient’s bedside or clinic setting. An appropriately trained nurse may carry out the procedure, although any concerns regarding possible infection, hematoma, or wound dehiscence warrant review by a physician.[22]
In cases where ultrasound-guided aspiration is required, this can be referred to a radiologist if the clinician is not appropriately trained.
Preparation
Following correct patient identification, assessment should begin with history and examination to ascertain indications for intervention. Informed consent must be obtained following a discussion of the risks and benefits of aspiration. Significant risks include pain, infection, the need for future procedures, and damage to surrounding structures.[20]
Other than possible damage to nerves, blood vessels, and tendons, this includes implant damage in periprosthetic seromas and pneumothorax in chest wall seromas.[23]
A clean trolley should be used, and a sterile field should be set up with the equipment required. The aseptic non-touch technique must be adhered to throughout the procedure to minimize the risk of introducing infection. The clinician should use personal protective equipment, including gloves, an apron, a mask, and a visor, to minimize exposure to bodily fluids.
Technique or Treatment
After the patient has been appropriately positioned, the seroma should be examined to plan the aspiration point. This reduces the need for further palpation after skin preparation and minimizes the risk of introducing infection. An entry point through the surgical scar can be used to minimize the pain if feasible. If there is suspicion of infection, the clinician should be prepared to collect a sample for microscopy and culture.
The skin is prepared with a disinfectant wipe/device. A sterile drape with a central gap can be placed to isolate the aspiration site from surrounding unprepared skin. The needle entry point should be in the central aspect of the collection, and the needle advanced at a 45-degree angle to the skin and parallel to underlying structures. Once through the skin, the needle is gently advanced while aspirating on the syringe until there is a reduction in resistance and fluid is aspirated. If the seroma has not fully resolved but fluid stops withdrawing, the needle can be carefully re-positioned as there may be locations. If a repeated attempt is required, a new needle should be used, but multiple attempts should be limited to reduce the risk of infection.[22]
Once the seroma has resolved, the needle can be removed and gentle pressure applied with gauze to the injection site until hemostasis is achieved. A sterile dressing can then be applied. Seroma fluid should be clear in nature; if the collected sample is cloudy or purulent, the sample should be sent for analysis, and broad-spectrum antibiotics may be considered if an infection is suspected.
Following the procedure, arrangements should be made for an early follow-up to review for resolution or need for further aspiration.
Complications
Although seroma aspiration is generally considered a safe procedure, there are recognized complications that may occur:
- Bleeding
- Neurovascular damage
- Infection: All invasive procedures carry a risk of infection. The need for multiple aspirations increases this risk. It should be noted that evidence in the literature suggests large untreated seromas are associated with infection, and therefore a decision to aspirate should be based on a risk assessment by the clinician.[6][10]
- Implant damage: In periprosthetic seromas, such as following breast implant surgery, there is a risk of implant puncture and rupture during aspiration. This is a significant complication that may necessitate a return to theatre. This risk can be mitigated using ultrasound guidance and an intravenous cannula or blunt needle.[21][24]
- Pneumothorax: Aspiration of chest wall seromas carry the risk of damage to the underlying pleura, which may cause a pneumothorax. Any symptoms of acute shortness of breath or difficulty breathing during or immediately after aspiration warrant emergency assessment and consideration of obtaining a chest radiograph.
Clinical Significance
Seromas can form in any surgical wound where extensive soft tissue dissection and dead space creation occur. Patients often present 7 to 10 days following wound closure or wound drain removal with a fluctuant collection near the operative site. This can be asymptomatic or associated with pain, a functional deficit of the affected area, and/or wound dehiscence.
Common Differentials
- Hematoma: An abnormal collection of blood; this is often associated with bruising.
- Abscess: A collection of pus in a cavity surrounded by epithelium. This is associated with overlying erythema and a warm surface. The patient may become systemically unwell with pyrexia and raised inflammatory markers. Definitive management includes incision and drainage and antibiotic administration.
- Lymphedema: Tissue swelling caused by disruption to the lymphatic systems. It can occur following procedures where significant lymphatic resection occurs, such as axillary node clearance for breast cancer with nodal disease. Swelling can be localized or generalized to an entire limb.
Patients presenting with suspected seroma in the early postoperative period should be thoroughly evaluated with history and examination to rule out other differentials. Blood tests, including a complete blood count and c-reactive protein (CRP), may also aid in the diagnostic process, but results should be considered in the clinical context of the patient's presentation.
Ultrasonography is indicated in patients whose diagnosis is uncertain or whose multiple aspirations have failed to resolve the collection to investigate for pseudocyst formation.[18]
As previously discussed, aspiration provides therapeutic relief for large-volume, symptomatic seromas. Moreover, examining the appearance of the fluid aspirated can be useful in confirming the diagnosis. This would be clear/straw-colored fluid in a seroma, blood in a hematoma, and pus in an abscess.
Breast Cancer Surgery
Due to its high incidence following mastectomy and axillary surgery, in the literature, seroma is occasionally regarded as an adverse effect of the surgery as opposed to a complication. Current research focuses on prevention through different flap fixation techniques, using chemical agents, and intra-operative drain insertion, with conflicting evidence in different patient groups.[25]
However, in the context of breast reconstruction, the management of seroma can become more difficult due to the risk of implant loss and skin flap ischemia. Implant loss rates due to seroma formation have been reported to be between 2 to 8%.[26][27] This can occur through wound dehiscence or superimposed bacterial infection. Using a mesh for reconstruction has also increased seroma formation rates. Studies comparing the incidence of seroma in synthetic and biological meshes have found conflicting results.[26][28]
The decision to drain a seroma in the context of breast reconstructive surgery can be difficult for the surgeon, and the risks of introducing infection with subsequent implant loss must be weighed up against the patient's symptoms, risk of skin dehiscence/necrosis, and the degree of aesthetic effect on the reconstruction.[29][30]
Hernia Repair
Seroma formation is common following hernia repair surgery, with an incidence between 8 to 12.5% for open hernia repair and 5.4% for laparoscopic repair.[31] Other than the possible complications already associated with seroma formation, in this patient group, they can be incorrectly perceived as a recurrence of the hernia by the patient or their clinician, potentially leading to unnecessary operative intervention.[32][33][34] Careful clinical examination is required to differentiate these pathologies, and adjunct imaging (USS or CT) may be used in cases with diagnostic uncertainty.
Studies have been performed to investigate the role of mesh repair on the incidence of seroma formation. A Cochrane review found that repair with mesh is more likely to be complicated by seroma compared to the non-mesh repair, likely due to a more significant local reaction to the prosthesis. A meta-analysis by Fang et al. found higher rates of seroma formation with biologic mesh compared to those made of synthetic materials.[35]
The decision to aspirate seromas in patients following hernia repair with mesh should be carefully considered as it carries a risk of introducing infection to the underlying prosthesis. This significant complication is likely to require further revision surgery to remove the infected implant.[36]
Seroma following laparoscopic hernia repair should be considered an expected outcome rather than a complication, with studies showing 95 to 100% of patients having early postoperative seroma formation on USS/CT imaging. The seroma did not resolve spontaneously in only 3 or 4% of patients.[37]
Abdominoplasty
Abdominoplasty is one of the most common plastic surgery procedures, with seroma being the most common complication post-operatively; however, their incidence is decreasing, likely due to the wider use of successful intra-operative preventative measures.[6] These include quilting sutures, closed suction drainage, and Scarpa's fascia preservation.[6]
The use of tissue adhesives does not seem to reduce the incidence of seroma but rather reduces their volume.[9][38] Following the formation of seroma, aspiration remains the treatment modality for large and symptomatic collections. There is little evidence in the literature on the volume of fluid after which aspiration is recommended. Di Martino et al. used a cut-off of 20ml and found that 23.8% of patients undergoing abdominoplasty (without quilting sutures) required aspiration.
Enhancing Healthcare Team Outcomes
A multidisciplinary and interprofessional approach is essential in managing postoperative seroma to ensure positive patient outcomes and minimize risks of complications. Clinical nurse specialists (CNS) play a key role in postoperative follow-up and monitoring. In breast cancer surgery, on-demand nurse-led follow-up in suitable patients has shown to be safe and effective with high patient satisfaction. A CNS follow-up service provides a more accessible, consistent means for patients to be reviewed and educated in the postoperative period.[39] [Level 1]
Protocols have been developed for trained CNS-led aspiration of seromas with appropriate escalation for medical input when required.[22] [Level 5]
This allows for improved reallocation of time for the surgeon to focus on diagnosing and treating the underlying condition and reviewing complicated seromas. Symptomatic seromas refractory to aspiration or complicated by infection or wound dehiscence will be reviewed by the physician as different management strategies are likely to be required. This includes incision & drainage with antibiotics for abscess formation and surgical excision of pseudocysts.[16][17][18][19] [Level 5]
The radiologist can aid the diagnostic process by interpreting ultrasound or computed tomography (CT) imaging. They can also offer ultrasound-guided aspiration for periprosthetic breast seromas.
References
Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ journal of surgery. 2006 Dec:76(12):1088-95 [PubMed PMID: 17199696]
van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2011 Oct:37(10):829-35. doi: 10.1016/j.ejso.2011.04.012. Epub 2011 Aug 17 [PubMed PMID: 21849243]
Level 1 (high-level) evidenceKuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Effect of mechanical closure of dead space on seroma formation after breast surgery. Breast cancer (Tokyo, Japan). 2006:13(3):260-5 [PubMed PMID: 16929119]
Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. The American surgeon. 2000 May:66(5):444-50; discussion 450-1 [PubMed PMID: 10824744]
Level 2 (mid-level) evidenceTroost MS, Kempees CJ, de Roos MAJ. Breast cancer surgery without drains: no influence on seroma formation. International journal of surgery (London, England). 2015 Jan:13():170-174. doi: 10.1016/j.ijsu.2014.11.050. Epub 2014 Dec 6 [PubMed PMID: 25486263]
Level 2 (mid-level) evidenceSalari N, Fatahi B, Bartina Y, Kazeminia M, Heydari M, Mohammadi M, Hemmati M, Shohaimi S. The Global Prevalence of Seroma After Abdominoplasty: A Systematic Review and Meta-Analysis. Aesthetic plastic surgery. 2021 Dec:45(6):2821-2836. doi: 10.1007/s00266-021-02365-6. Epub 2021 Jun 2 [PubMed PMID: 34080041]
Level 1 (high-level) evidenceKuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Pathophysiology of seroma in breast cancer. Breast cancer (Tokyo, Japan). 2005:12(4):288-93 [PubMed PMID: 16286909]
Level 1 (high-level) evidenceAndrades P, Prado A, Danilla S, Guerra C, Benitez S, Sepulveda S, Sciarraffia C, De Carolis V. Progressive tension sutures in the prevention of postabdominoplasty seroma: a prospective, randomized, double-blind clinical trial. Plastic and reconstructive surgery. 2007 Sep 15:120(4):935-946. doi: 10.1097/01.prs.0000253445.76991.de. Epub [PubMed PMID: 17805122]
Level 1 (high-level) evidenceSeretis K, Goulis D, Demiri EC, Lykoudis EG. Prevention of Seroma Formation Following Abdominoplasty: A Systematic Review and Meta-Analysis. Aesthetic surgery journal. 2017 Mar 1:37(3):316-323. doi: 10.1093/asj/sjw192. Epub [PubMed PMID: 28158391]
Level 1 (high-level) evidenceUnalp HR, Onal MA. Analysis of risk factors affecting the development of seromas following breast cancer surgeries: seromas following breast cancer surgeries. The breast journal. 2007 Nov-Dec:13(6):588-92 [PubMed PMID: 17983401]
Level 2 (mid-level) evidenceJanis JE, Khansa L, Khansa I. Strategies for Postoperative Seroma Prevention: A Systematic Review. Plastic and reconstructive surgery. 2016 Jul:138(1):240-252. doi: 10.1097/PRS.0000000000002245. Epub [PubMed PMID: 27348657]
Level 1 (high-level) evidenceGantwerker EA, Hom DB. Skin: histology and physiology of wound healing. Facial plastic surgery clinics of North America. 2011 Aug:19(3):441-53. doi: 10.1016/j.fsc.2011.06.009. Epub [PubMed PMID: 21856533]
Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing. Plastic and reconstructive surgery. 2006 Jun:117(7 Suppl):12S-34S [PubMed PMID: 16799372]
Klink CD, Binnebösel M, Lucas AH, Schachtrupp A, Klinge U, Schumpelick V, Junge K. Do drainage liquid characteristics serve as predictors for seroma formation after incisional hernia repair? Hernia : the journal of hernias and abdominal wall surgery. 2010 Apr:14(2):175-9. doi: 10.1007/s10029-009-0603-1. Epub 2009 Dec 10 [PubMed PMID: 19998048]
Tadych K, Donegan WL. Postmastectomy seromas and wound drainage. Surgery, gynecology & obstetrics. 1987 Dec:165(6):483-7 [PubMed PMID: 3686312]
Level 2 (mid-level) evidenceMorris BE, Thornburg DA, Teven CM, Kruger EA. Surgical Management of Chronic Encapsulated Abdominal Wall Seroma 8 Years after Abdominoplasty. Plastic and reconstructive surgery. Global open. 2021 Jul:9(7):e3697. doi: 10.1097/GOX.0000000000003697. Epub 2021 Jul 20 [PubMed PMID: 34422519]
Caulfield RH, Maleki-Tabrizi A, Khan F, Ramakrishnan V. A large encapsulated seroma presenting as a mass 5 years post paraumbilical hernia repair. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2009 Jan:62(1):105-7 [PubMed PMID: 17933597]
Level 3 (low-level) evidenceGoldman A, Wollina U, França K, Tchernev G, Lotti T. Chronic Encapsulated Seroma Persisting for Three Years after Abdominoplasty and a Successful Surgical Solution. Open access Macedonian journal of medical sciences. 2018 Jan 25:6(1):82-84. doi: 10.3889/oamjms.2018.051. Epub 2018 Jan 9 [PubMed PMID: 29483991]
Fosheim K, Bojesen S, Troestrup H, Laenkholm AV. Capsulectomy Can Successfully Treat Chronic Encapsulated Breast Seroma: A Case Report. Cureus. 2022 Jan:14(1):e21677. doi: 10.7759/cureus.21677. Epub 2022 Jan 27 [PubMed PMID: 35237476]
Level 3 (low-level) evidenceTurner EJ, Benson JR, Winters ZE. Techniques in the prevention and management of seromas after breast surgery. Future oncology (London, England). 2014 May:10(6):1049-63. doi: 10.2217/fon.13.257. Epub [PubMed PMID: 24941989]
Level 1 (high-level) evidenceLee J, Park HY, Kim WW, Park CS, Lee RK, Yang JD, Lee JS, Jung JH. Comparison between ultrasound-guided aspiration performed using an intravenous cannula or a conventional needle in patients with peri-prosthetic seroma. Medicine. 2019 Dec:98(51):e18511. doi: 10.1097/MD.0000000000018511. Epub [PubMed PMID: 31861038]
Warren M. Collaboration in developing a protocol for nurse-led seroma aspiration. British journal of nursing (Mark Allen Publishing). 2008 Aug 14-Sep 10:17(15):956-60 [PubMed PMID: 18983016]
Park JE, Nigam M, Shenaq DS, Song DH. A simple, safe technique for thorough seroma evacuation in the outpatient setting. Plastic and reconstructive surgery. Global open. 2014 Sep:2(9):e212. doi: 10.1097/GOX.0000000000000179. Epub 2014 Oct 7 [PubMed PMID: 25426395]
Becker H, Klimczak J. Aspiration of Periprosthetic Seromas Using the Blunt SeromaCath. Plastic and reconstructive surgery. 2016 Feb:137(2):473-475. doi: 10.1097/01.prs.0000475795.84725.c4. Epub [PubMed PMID: 26818281]
Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. Journal of breast cancer. 2012 Dec:15(4):373-80. doi: 10.4048/jbc.2012.15.4.373. Epub 2012 Dec 31 [PubMed PMID: 23346164]
Radu MA, Blidaru A. Persistent Seroma, a Threat to Implant-Based Breast Reconstruction? Chirurgia (Bucharest, Romania : 1990). 2021 Mar-Apr:116(2):201-208. doi: 10.21614/chirurgia.116.2.201. Epub [PubMed PMID: 33950816]
Berna G, Cawthorn SJ, Papaccio G, Balestrieri N. Evaluation of a novel breast reconstruction technique using the Braxon(®) acellular dermal matrix: a new muscle-sparing breast reconstruction. ANZ journal of surgery. 2017 Jun:87(6):493-498. doi: 10.1111/ans.12849. Epub 2014 Sep 29 [PubMed PMID: 25266930]
Level 3 (low-level) evidenceHansson E, Edvinsson AC, Hallberg H. Drain secretion and seroma formation after immediate breast reconstruction with a biological and a synthetic mesh, respectively: A randomized controlled study. The breast journal. 2020 Sep:26(9):1756-1759. doi: 10.1111/tbj.13921. Epub 2020 Jun 9 [PubMed PMID: 32515840]
Level 1 (high-level) evidenceMoyer KE, Potochny JD. Technique for seroma drainage in implant-based breast reconstruction. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2012 Dec:65(12):1614-7. doi: 10.1016/j.bjps.2012.06.016. Epub 2012 Jul 6 [PubMed PMID: 22770571]
Level 2 (mid-level) evidenceBrzezienski MA, Jarrell JA 4th, Mooty RC. Classification and management of seromas in immediate breast reconstruction using the tissue expander and acellular dermal matrix technique. Annals of plastic surgery. 2013 May:70(5):488-92. doi: 10.1097/SAP.0b013e31827eac93. Epub [PubMed PMID: 23542848]
Level 2 (mid-level) evidenceBedi AP, Bhatti T, Amin A, Zuberi J. Laparoscopic incisional and ventral hernia repair. Journal of minimal access surgery. 2007 Jul:3(3):83-90. doi: 10.4103/0972-9941.37190. Epub [PubMed PMID: 19789663]
Kaafarani HM, Hur K, Hirter A, Kim LT, Thomas A, Berger DH, Reda D, Itani KM. Seroma in ventral incisional herniorrhaphy: incidence, predictors and outcome. American journal of surgery. 2009 Nov:198(5):639-44. doi: 10.1016/j.amjsurg.2009.07.019. Epub [PubMed PMID: 19887192]
Level 1 (high-level) evidencePring CM, Tran V, O'Rourke N, Martin IJ. Laparoscopic versus open ventral hernia repair: a randomized controlled trial. ANZ journal of surgery. 2008 Oct:78(10):903-6. doi: 10.1111/j.1445-2197.2008.04689.x. Epub [PubMed PMID: 18959646]
Level 1 (high-level) evidenceKeidar A, Kanitkar S, Szold A. Laparoscopic repair of recurrent inguinal hernia. Surgical endoscopy. 2002 Dec:16(12):1708-12 [PubMed PMID: 12140639]
Level 2 (mid-level) evidenceFang Z, Ren F, Zhou J, Tian J. Biologic mesh versus synthetic mesh in open inguinal hernia repair: system review and meta-analysis. ANZ journal of surgery. 2015 Dec:85(12):910-6. doi: 10.1111/ans.13234. Epub 2015 Jul 17 [PubMed PMID: 26183816]
Level 1 (high-level) evidenceNarkhede R, Shah NM, Dalal PR, Mangukia C, Dholaria S. Postoperative Mesh Infection-Still a Concern in Laparoscopic Era. The Indian journal of surgery. 2015 Aug:77(4):322-6. doi: 10.1007/s12262-015-1304-x. Epub 2015 Jun 27 [PubMed PMID: 26702240]
Earle D, Roth JS, Saber A, Haggerty S, Bradley JF 3rd, Fanelli R, Price R, Richardson WS, Stefanidis D, SAGES Guidelines Committee. SAGES guidelines for laparoscopic ventral hernia repair. Surgical endoscopy. 2016 Aug:30(8):3163-83. doi: 10.1007/s00464-016-5072-x. Epub 2016 Jul 12 [PubMed PMID: 27405477]
Nasr MW, Jabbour SF, Mhawej RI, Elkhoury JS, Sleilati FH. Effect of Tissue Adhesives on Seroma Incidence After Abdominoplasty: A Systematic Review and Meta-Analysis. Aesthetic surgery journal. 2016 Apr:36(4):450-8. doi: 10.1093/asj/sjv276. Epub 2016 Jan 28 [PubMed PMID: 26821643]
Level 1 (high-level) evidenceKoinberg IL, Fridlund B, Engholm GB, Holmberg L. Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. European journal of oncology nursing : the official journal of European Oncology Nursing Society. 2004 Jun:8(2):109-17; discussion 118-20 [PubMed PMID: 15171968]
Level 1 (high-level) evidence